Time recall; future concept of chronomodulating chemotherapy for cancer

Paul Zarogoulidis, Kaid Darwiche, Haidong Huang, Dionysis Spyratos, Lonny Yarmus, Qiang Li, Stylianos Kakolyris, Konstantinos Syrigos, Konstantinos Zarogoulidis

Research output: Contribution to journalReview article

Abstract

The human metabolism is regulated by our internal clock; the circadian rhythm (24h-25h). There are several factors included in the regulatory pathway such as; genes (PER1-3), (CRY1-2), TIM hormones (cortisol, catecholamines, melatonin and insulin) drugs, enzymes, sleep disorders and diseases. Each one contributes in a different degree and in order to enhance the therapeutic result; we should include these factors into clusters instead of targeting each factor one by one. Malignances deregulate gene-protein expression/production, enzyme production, and in addition they induce fatigue, insomnia, stress and sleep disorders. All these factors finally contribute in minimizing the efficiency of chemotherapy treatment and quality of life. In addition, the circadian rhythm disruption induces tumor genesis, stress, and downregulates the defense and repair mechanisms of the human body. In the current mini review the underlying mechanism of the circadian rhythm is provided, along with the influence of sleep disturbances in cancer patient therapy. A proposal is presented to divide circadian rhythm and sleep disturbances into two major clusters with different management, however; with a common target to improve treatment efficiency and quality of life. Finally, a chrono-chemotherapy administration model is proposed in order to have less chemotherapy side effects.

Original languageEnglish (US)
Pages (from-to)632-642
Number of pages11
JournalCurrent Pharmaceutical Biotechnology
Volume14
Issue number6
DOIs
StatePublished - Jan 1 2013

    Fingerprint

Keywords

  • Cancer
  • Chemotherapy
  • Chronomodulation
  • Circadian rhythm
  • Sleep disorders

ASJC Scopus subject areas

  • Biotechnology
  • Pharmaceutical Science

Cite this

Zarogoulidis, P., Darwiche, K., Huang, H., Spyratos, D., Yarmus, L., Li, Q., Kakolyris, S., Syrigos, K., & Zarogoulidis, K. (2013). Time recall; future concept of chronomodulating chemotherapy for cancer. Current Pharmaceutical Biotechnology, 14(6), 632-642. https://doi.org/10.2174/13892010113146660229